2131 DEVELOPMENT AND VALIDATION OF THE BIOPSY-BASED GENOMIC PROSTATE SCORE (GPS) AS A PREDICTOR OF HIGH GRADE OR EXTRACAPSULAR PROSTATE CANCER TO IMPROVE PATIENT SELECTION FOR ACTIVE SURVEILLANCE
- 30 April 2013
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 189 (4), e873
- https://doi.org/10.1016/j.juro.2013.02.2040